Free Trial
NYSE:AVNS

AVANOS MEDICAL (AVNS) Stock Price, News & Analysis

AVANOS MEDICAL logo
$12.27 -0.06 (-0.49%)
Closing price 03:56 PM Eastern
Extended Trading
$12.28 +0.01 (+0.08%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About AVANOS MEDICAL Stock (NYSE:AVNS)

Key Stats

Today's Range
$12.04
$12.33
50-Day Range
$11.87
$13.12
52-Week Range
$11.68
$25.36
Volume
278,210 shs
Average Volume
385,016 shs
Market Capitalization
$567.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AVANOS MEDICAL Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

AVNS MarketRank™: 

AVANOS MEDICAL scored higher than 52% of companies evaluated by MarketBeat, and ranked 767th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for AVANOS MEDICAL.

  • Earnings Growth

    Earnings for AVANOS MEDICAL are expected to grow by 31.06% in the coming year, from $1.32 to $1.73 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AVANOS MEDICAL is 8.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AVANOS MEDICAL is 8.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.07.

  • Price to Book Value per Share Ratio

    AVANOS MEDICAL has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about AVANOS MEDICAL's valuation and earnings.
  • Percentage of Shares Shorted

    3.73% of the float of AVANOS MEDICAL has been sold short.
  • Short Interest Ratio / Days to Cover

    AVANOS MEDICAL has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in AVANOS MEDICAL has recently increased by 7.05%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    AVANOS MEDICAL does not currently pay a dividend.

  • Dividend Growth

    AVANOS MEDICAL does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.73% of the float of AVANOS MEDICAL has been sold short.
  • Short Interest Ratio / Days to Cover

    AVANOS MEDICAL has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in AVANOS MEDICAL has recently increased by 7.05%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    AVANOS MEDICAL has a news sentiment score of -1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for AVANOS MEDICAL this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, AVANOS MEDICAL insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.64% of the stock of AVANOS MEDICAL is held by insiders.

  • Percentage Held by Institutions

    95.17% of the stock of AVANOS MEDICAL is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AVANOS MEDICAL's insider trading history.
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVANOS MEDICAL and its competitors with MarketBeat's FREE daily newsletter.

AVNS Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Q1 2025 Avanos Medical Inc Earnings Call
See More Headlines

AVNS Stock Analysis - Frequently Asked Questions

AVANOS MEDICAL's stock was trading at $15.92 at the start of the year. Since then, AVNS shares have decreased by 22.9% and is now trading at $12.27.

AVANOS MEDICAL, INC. (NYSE:AVNS) announced its quarterly earnings results on Tuesday, May, 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.19 by $0.07. The business's revenue was up .8% compared to the same quarter last year.
Read the conference call transcript
.

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVANOS MEDICAL investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/06/2025
Today
7/09/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:AVNS
CIK
1606498
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
9.27
P/E Growth
N/A
Net Income
-$392.10 million
Pretax Margin
-57.33%

Debt

Sales & Book Value

Annual Sales
$687.80 million
Cash Flow
$12.24 per share
Price / Cash Flow
1.00
Book Value
$18.03 per share
Price / Book
0.68

Miscellaneous

Free Float
45,023,000
Market Cap
$565.98 million
Optionable
Optionable
Beta
1.12
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:AVNS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners